FDA to ease copycat drug rules, speeding access to cheaper drugs

The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to cheaper alternatives.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup